Intravesical delivery of 5-aminolevulinic acid from water-in-oil nano/submicron-emulsion systems

Journal of Pharmaceutical Sciences

Volumn 99, Issue 5, 2010, Pages 2375-2385

  Fang, Jia You ^a   Wu, Pao Chu ^b   Fang, Chia Lang ^c   Chen, Chao Huang ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 aminolevulinic acid; Bladder; Emulsion; Intravesical delivery; Sustained release

Indexed keywords

AMINOLEVULINIC ACID; OIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONFOCAL LASER MICROSCOPY; CONTROL GROUP; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NANOEMULSION; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SUSTAINED DRUG RELEASE; VISCOSITY; ZETA POTENTIAL;

EID: 77951277133     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22006     Document Type: Article

References (42)

1. Witjes JA, Hendricksen K. 2008. Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: A critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53:45-52. (Pubitemid 350167566)
2. Shen Z, Shen T, Wientjes MG, O'Donnell MA, Au JLS. 2008. Intravesical treatments of bladder cancer: Review. Pharm Res 25:1500-1510.
3. Giannantoni A, Di Stasi SM, Chancellor MB, Costantini E, Porena M. 2006. New frontiers in intravesical therapies and drug delivery. Eur Urol 50:1183-1193. (Pubitemid 44692939)
4. Dalton JT, Yates CR, Yin D, Straughn A, Marcus SL, Golub AL, Meyer MC. 2002. Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers, and patients at high risk for recurrent bladder cancer. J Pharmacol Exp Ther 301:507-512. (Pubitemid 34429961)
5. de Vere White RW. 2006. Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: Are there any longterm benefits? Nat Clin Pract Urol 3:254-255.
6. Babjuk M, Soukup V, Petrik R, Jirsa M, Dvorácek J. 2005. 5- aminolaevulinic acid-induced fluorescence cytoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 96:798-802. (Pubitemid 41391384)
7. Denzinger S, Burger M, Walter B, Knuechel R, Roessler W, Wieland WF, Filbeck T. 2007. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-amino-levulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 69:675-679. (Pubitemid 46574917)
8. Lee SJ, Kim SW, Chung H, Park YT, Choi YW, Cho YH, Yoon MS. 2005. Bioadhesive drug delivery system, using glyceryl monooleate for the intravesical administration of paclitaxel. Chemotherapy 51:311-318. (Pubitemid 41546705)
9. Bunke A, Zerbe O, Schmid H, Burmeister G, Merkle HP, Gander B. 2000. Degradation mechanism and stability of 5-aminolevulinic acid. J Pharm Sci 89:1335-1341.
10. Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang L. 2006. Recent advances in intravesical drug/gene delivery. Mol Pharm 3:369-379. (Pubitemid 44351919)
11. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma M.J. 2005. Nano-emulsions. Curr Opin Colloid Interface Sci 10:102-110.
12. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, Roessler BJ. 2001. Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 221:23-34. (Pubitemid 32524032)
13. Wang JJ, Hung CF, Yeh CH, Fang JY. 2008. The release and analgesic activities of morphine and its ester prodrug, morphine propionate, as formulated by water-in-oil nanoemulsions. J Drug Target 16:294-301.
14. Kirchmann H, Pettersson S. 1994. Human urine: Chemical composition and fertilizer use efficiency. Nutr Cycl Agroecosyst 40:149-154.
15. Oishi H, Nomiyama H, Nomiyama K, Tomokuni K. 1996. Fluorometric HPLC determination of 5-aminolevulinic acid in the plasma and urine of lead workers: Biological indicators of lead exposure. J Anal Toxicol 20:106-110. (Pubitemid 26085459)
16. Shen SC, Lee WR, Fang YP, Hu CH, Fang JY. 2006. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium: YAG laser. J Pharm Sci 95:929-938.
17. Datta SN, Allman R, Loh CS, Mason M, Matthews PN. 1997. Photodynamic therapy of bladder cancer cell lines. Br J Urol 80:421-426. (Pubitemid 28312848)
18. Tyagi P, Li Z, Chancellor M, De Groat WC, Yoshimura N, Huang L. 2004. Sustained intravesical drug delivery using thermosensitive hydrogel. Pharm Res 21:832-837. (Pubitemid 39011308)
19. Madhusudhan B, Rambhau D, Apte SC, Gopinath D. 2007. 1-OAlkylglycerol stabilized carbamazepine intravenous o/w nanoemulsions for drug targeting in mice. J Drug Target 15:154-161. (Pubitemid 46957702)
20. Hung CF, Chen JK, Liao MH, Lo HM, Fang JY. 2006. Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol 6:2950-2958.
21. Yamaguchi T. 1996. Lipid microspheres as drug carriers: A pharmaceutical point of view. Adv Drug Deliv Rev 20:117-130. (Pubitemid 26284152)
22. Buszello K, Harnisch S, Müller RH, Müller BW. 2000. The influence of alkali fatty acids on the properties and the stability of parenteral o/w emulsions modified with Solutol HS15®. Eur J Pharm Biopharm 49:143-149. (Pubitemid 30126062)
23. Spernath A, Aserin A, Ziserman L, Danino D, Garti N. 2007. Phosphatidylcholine embedded microemulsions: Physical properties and improved Caco-2 cell permeability. J Control Release 119:279-290. (Pubitemid 46770876)
24. Bouchemal K, Briançon S, Perrier E, Fessi H. 2004. Nanoemulsion formation using spontaneous emulsification: Solvent, oil and surfactant optimization. Int J Pharm 280:241-251.
25. Wang JJ, Sung KC, Hu OYP, Yeh CH, Fang JY. 2006. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Control Release 115:140-149.
26. Mason TG. 2000. Estimating the viscoelastic moduli of complex fluids using the generalized Stokes-Einstein equation. Rheol Acta 39:371-378.
27. Nielsen HM, Aemisegger C, Burmeister G, Schuchter U, Gander B. 2004. Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells. Pharm Res 21:2253-2260. (Pubitemid 40568439)
28. Elfsson B, Wallin I, Eksborg S, Rudaeus K, Ros AM, Ehrsson H. 1998. Stability of 5-aminolevulinic acid in aqueous solution. Eur J Pharm Sci 7:87-91.
29. Bjerregaard S, Söderberg I, Vermehren C, Frokjaer S. 1999. Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design. Int J Pharm 193:1-11.
30. Yoshioka T, Florence AT. 1994. Vesicle (noisome)-in-water-inoil (v/w/o) emulsions: An in vitro study. Int J Pharm 108:117-123. (Pubitemid 124013809)
31. Chung H, Kim TW, Kwon M, Kwon IC, Jeong SY. 2001. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. J Control Release 71:339-350. (Pubitemid 32276053)
32. Spernath A, Aserin A. 2006. Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci 128-130:47-64.
33. Jager-Lezer N, Terrisse I, Bruneau F, Tokgoz S, Ferreira L, Clausse D, Seiller M, Grossiord JL. 1997. Influence of lipophilic surfactant on the release kinetics of water-soluble molecules entrapped in a w/o/w multiple emulsion. J Control Release 45:1-13. (Pubitemid 27055787)
34. Bjerregaard S, Söderberg I, Vermehren C, Frokjaer S. 1999. The effect of controlled osmotic stress on release and swelling properties of a water-in-oil emulsion. Int J Pharm 183:17-20. (Pubitemid 29248820)
35. Vasir JK, Labhasetwar VD. 2005. Nanosystems in drug targeting: Opportunities and challenges. Curr Nanosci 1:47-64.
36. Hatefi A, Amsden B. 2002. Camptothecin delivery methods. Pharm Res 19:1389-1399.
37. Lu Z, Yeh TK, Tsai M, Au JLS, Wientjes MG. 2004. Paclitaxelloaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 10:7677-7684. (Pubitemid 39557532)
38. Grabnar I, Bogataj M, Belič A, Logar V, Karba R, Mrhar A. 2006. Kinetic model of drug distribution in the urinary bladder wall following intravesical instillation. Int J Pharm 322:52-59. (Pubitemid 44331525)
39. Tadros T, Izquierdo P, Esquena J, Solans C. 2004. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 108-109:303-318.
40. Wagner HA, Groebe G, Engelmann U. 1988. Serum and tissue levels of platinum after cisplatinum instillation of the rat bladder. Urol Res 16:85-88. (Pubitemid 18089115)
41. Sylvester RJ, Oosterlinck W, Witjes JA. 2008. The schedule and duration of intravesical chemotherapy in patients with nonmuscle-invasive bladder cancer: A systematic review of the published results of randomized clinical trials. Eur Urol 53:709-719.
42. Le Visage C, Rioux-Leclercq N, Haller M, Breton P, Malavaud B, Leong K. 2004. Efficacy of paclitaxel released from bioadhesive polymer microspheres on model superficial bladder cancer. J Urol 171:1324-1329. (Pubitemid 38327604)